Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3064503 | Journal of Neuroimmunology | 2011 | 7 Pages |
Abstract
We determined the T-cell responses against botulinum neurotoxin type A (BoNT/A) and tetanus toxin (TeNT) of peripheral blood lymphocytes from 95 BoNT-treated patients and 63 non-treated control subjects. The patient group included 80 cervical dystonia and 15 other movement disorder cases. Positive T-cell responses to BoNT/A were detected in 70% of the treated patients, and in only 3% of controls. T-cell responses of BoNT-treated patients against BoNT/A did not differ between patients who were clinically responsive and those who had become non-responsive to the treatment. BoNT-treated patients gave significantly higher in vitro T-cell responses to TeNT than did the controls.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Minako Oshima, Philip R. Deitiker, Joseph Jankovic, Drake D. Duane, K. Roger Aoki, M. Zouhair Atassi,